Prelude Therapeutics Ownership | Who Owns Prelude Therapeutics?
Prelude Therapeutics Ownership Summary
Prelude Therapeutics is owned by 5.62% institutional investors, 9.36% insiders, and 85.02% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.38% of PRLD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.31% of its assets in Prelude Therapeutics shares.
PRLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Prelude Therapeutics | 5.62% | 9.36% | 85.02% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 14.38% | $13.91M |
| Baker bros. advisors lp | 10.12M | 13.35% | $12.91M |
| Boxer capital | 2.57M | 3.39% | $9.79M |
| Blackrock | 1.07M | 1.41% | $4.07M |
| Blackrock funding, inc. /de | 1.07M | 1.41% | $1.36M |
| Price t rowe associates inc /md/ | 1.03M | 1.36% | $1.31M |
| Vanguard group | 1.01M | 1.33% | $1.29M |
| Renaissance | 634.50K | 0.84% | $808.99K |
| Massachusetts financial services co /ma/ | 494.50K | 0.65% | $630.48K |
| Acadian asset management | 485.38K | 0.64% | $617.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital | 2.57M | 0.52% | $9.79M |
| Orbimed advisors | 10.91M | 0.29% | $13.91M |
| Baker bros. advisors lp | 10.12M | 0.14% | $12.91M |
| Xtx topco | 38.34K | 0.00% | $48.88K |
| Bridgeway capital management | 111.00K | 0.00% | $141.53K |
| Acadian asset management | 485.38K | 0.00% | $617.00K |
| Exchange traded concepts | 64.41K | 0.00% | $82.12K |
| Renaissance | 634.50K | 0.00% | $808.99K |
| Two sigma advisers, lp | 300.00K | 0.00% | $382.50K |
| Marshall wace, llp | 392.15K | 0.00% | $498.04K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 634.50K | 0.00% | 437.60K |
| Acadian asset management | 485.38K | 0.00% | 411.24K |
| Millennium management | 462.56K | 0.00% | 302.03K |
| Two sigma advisers, lp | 300.00K | 0.00% | 252.10K |
| Two sigma investments, lp | 231.84K | 0.00% | 174.91K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -3.77M |
| Exoduspoint capital management, lp | - | - | -921.62K |
| Avidity partners management lp | - | - | -890.00K |
| Sio capital management | - | - | -320.39K |
| T. rowe price investment management | - | - | -281.58K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna group, llp | 72.80K | - | 72.80K | $92.82K |
| Bnp paribas arbitrage, snc | 20.57K | - | 20.57K | $26.23K |
| Aqr capital management | 12.49K | - | 12.49K | $15.93K |
| Vanguard personalized indexing management | 11.93K | 0.00% | 11.93K | $15.20K |
| Cwm | 1.90K | - | 1.90K | $2.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Capital performance advisors llp | -8.00 |
| Srs capital advisors | -19.00 |
| Russell investments group | -76.00 |
| Amalgamated bank | -334.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 22 | -69.01% | 4,265,950 | -88.07% | 5 | 0.25% | 12 | -67.57% | 4 | -78.95% |
| Sep 30, 2024 | 71 | 14.52% | 35,754,682 | 5.42% | 47 | 2.35% | 37 | 48.00% | 19 | -9.52% |
| Jun 30, 2024 | 62 | 6.90% | 33,917,495 | -0.86% | 44 | 1.39% | 25 | 13.64% | 21 | -4.55% |
| Mar 31, 2024 | 58 | 1.75% | 34,212,156 | -1.48% | 56 | 1713434.09% | 22 | -35.29% | 22 | 57.14% |
| Dec 31, 2023 | 57 | -3.39% | 34,725,237 | -5.16% | - | 0.00% | 34 | 13.33% | 14 | -12.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 720.43K | 1.31% | - |
| Vanguard US Total Market Shares ETF | 720.43K | 1.31% | - |
| T. Rowe Price Health Sciences | 716.24K | 1.30% | - |
| iShares Russell 2000 ETF | 365.72K | 0.66% | -3.19K |
| Biotech Growth Ord | 346.50K | 0.63% | - |
| MFS New Discovery I | 327.70K | 0.60% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 207.51K | 0.38% | - |
| T. Rowe Price Small-Cap Value | 168.61K | 0.31% | -90.00 |
| Fidelity Small Cap Index | 145.00K | 0.26% | -2.71K |
| iShares Russell 2000 Value ETF | 124.63K | 0.23% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2025 | Combs Andrew | Chief Chemistry Officer | Buy | $69.25K |
| Mar 25, 2025 | Vaddi Krishna | CEO | Buy | $467.44K |
| Mar 20, 2025 | Vaddi Krishna | CEO | Buy | $3.95K |
| Mar 21, 2025 | Vaddi Krishna | CEO | Buy | $10.96K |
| Mar 17, 2025 | Vaddi Krishna | CEO | Buy | $6.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 8 | - |
| 2024 Q4 | 7 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
PRLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools